Clevidipine induced intrapulmonary shunting in a patient with acute type B aortic dissection

Authors

• Mit Chauhan Department of Pulmonary and Critical Care, Saint Michael’s Medical Center, Newark, USA; Department of Graduate Medical Education, New York Medical College, Valhalla, USA
• Masara Touza Department of Graduate Medical Education, New York Medical College, Valhalla, USA; Department of Internal Medicine, Saint Michael’s Medical Center, Newark, USA
• John Paul Fox Department of Graduate Medical Education, New York Medical College, Valhalla, USA; Department of Internal Medicine, Saint Michael’s Medical Center, Newark, USA
• Asma Jamil Department of Pulmonary and Critical Care, Saint Michael’s Medical Center, Newark, USA; Department of Graduate Medical Education, New York Medical College, Valhalla, USA
• Ruhma Ali Department of Pulmonary and Critical Care, Saint Michael’s Medical Center, Newark, USA; Department of Graduate Medical Education, New York Medical College, Valhalla, USA
• Alan Klukowicz Department of Pulmonary and Critical Care, Saint Michael’s Medical Center, Newark, USA; Department of Graduate Medical Education, New York Medical College, Valhalla, USA
• Nirav Mistry Department of Pulmonary and Critical Care, Saint Michael’s Medical Center, Newark, USA; Department of Graduate Medical Education, New York Medical College, Valhalla, USA

mit.chauhan.md@gmail.com

Keywords

Abstract

Clevidipine is a short acting calcium channel blocker commonly used to treat uncontrolled hypertension. The common side-effects include depression, dizziness, and headache. Hypoxia from intrapulmonary shunting after clevidipine use has not been widely reported in the literature. We present a case of acute type B aortic dissection treated with esmolol and clevidipine complicated by hypoxia which resolved post discontinuation of clevidipine.

References